Evogene Shares Fell on Lower Revenues and Earnings
Evogene recently reported poor results for the first half of 2016. Its revenues for the six months declined to $3.8 million, over $5.4 million for the same period last year. Its revenue for Q2 declined to 1.8 million, compared with revenue of $2.7 million for the same period in 2015.
This decay mirrors the net diminishing in such innovative work installments as per the work arrangements being sought after under the Company’s different coordinated effort understandings. It incorporates changes in the degree and sort of exercises attempted by the Company as a